BioStock Studio: Xintela expands to venous leg ulcers

Xintela has broadened the clinical development of its stem cell product XSTEM to include venous leg ulcers, the most common form of difficult-to-heal wounds...

Chordate Medical strengthens its Board of Directors

Caroline Lundgren Brandberg was recently elected as a member of medtech company Chordate Medical’s Board of Directors. With a long career in sales, marketing...

BioStock Studio: Alligator Bioscience’s long-term value driver

Alligator Bioscience has just announced that it is carrying out a rights issue worth approximately 257 million SEK. CEO Søren Bregenholt came by the BioStock Studio...

DanCann Pharma’s CEO on the new acquisition

Danish biotech DanCann Pharma has acquired CannGros, the leading distributor of medical cannabis in Denmark. Through the acquisition, Dancann obtained licenses to import and...
Martin Andersson, Chief Scientific OfficerSprint Bioscience

Sprint Bioscience initiates marketing of the DISA-program

The preclinical development experts at Sprint Bioscience started the second half of the year by signing the company's largest licensing agreement to date in...

BioInvent’s CEO on the benefits of a diversified portfolio

In just three years, immuno-oncology company BioInvent has expanded its project portfolio and advanced from one to soon five drug candidates in clinical phase...

Competitive landscape opens opportunities for Stayble Therapeutics

Almost everyone gets back pain at some point and for some the pain persists for a long time. In about 40 per cent of...

Saniona strengthens its board of directors

Recently, financial expert Robert E. Hoffman was added to the board of directors of the biotech company Saniona. Hoffman, a seasoned financial executive with...
Co-founder and CBO Niels Møller Evaxion Biotech

Evaxion Biotech leverages AI to fight cancer and infectious diseases

The development of new medicines is a long and costly process, often associated with uncertainty and risk. US listed Evaxion Biotech has developed an...

Market report predicts strong growth for Chordate Medical’s technology

About 1 billion people worldwide suffer from migraine making it the third most common disease and the most common neurological disease. Chordate Medical targets...